Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$609.30 USD

609.30
424,874

+11.27 (1.89%)

Updated Aug 6, 2024 12:08 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (99 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

EDAP TMS (EDAP) Catches Eye: Stock Jumps 7.4%

by Zacks Equity Research

EDAP TMS (EDAP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Nalak Das headshot

5 Top-Ranked Stocks Poised to Beat on Q2 Earnings This Week

by Nalak Das

We have narrowed down our search to five Zacks Rank #1 stocks slated to release earrings results this week with a positive Earnings ESP.

Testing Volume to Aid Quest Diagnostics' (DGX) Q2 Earnings?

by Zacks Equity Research

Looking at this demand for testing, Quest Diagnostics (DGX) has significantly picked up capacity to perform molecular diagnostic tests a day.

What's in Store for West Pharmaceutical's (WST) Q2 Earnings?

by Zacks Equity Research

West Pharmaceutical Services (WST) is likely to have gained from continued strength in high-value product sales in Q2.

What's in the Cards for Intuitive Surgical (ISRG) Q2 Earnings?

by Zacks Equity Research

Intuitive Surgical's (ISRG) second-quarter earnings are likely to reflect weaker-than-expected performance at Instruments & Accessories segment and decline in da Vince procedure volume.

Top Ranked Momentum Stocks to Buy for July 17th

by Zacks Equity Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 17th

3 Inexpensive MedTech Gainers of 2H20 Beyond TMO and RMD

by Zacks Equity Research

Here we look at three cheap MedTech stocks that investors can take a look at apart from giants like Thermo Fisher and ResMed that are expensive.

Luminex (LMNX) Catches Eye: Stock Jumps 7.1%

by Zacks Equity Research

Luminex (LMNX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

What's in Store for Edwards Lifesciences (EW) in Q2 Earnings?

by Zacks Equity Research

Robust customer adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve are likely to have driven Edwards Lifesciences' (EW) Q2 revenues.

Soliton (SOLY) Looks Good: Stock Adds 6.5% in Session

by Zacks Equity Research

Soliton (SOLY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Thermo Fisher Scientific (TMO) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Align Technology (ALGN) to Post Q2 Earnings: What's in Store?

by Zacks Equity Research

Align Technology (ALGN) is expected to have gained from continued strength in Clear Aligner shipment volumes in Q2.

Thermo Fisher (TMO) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

The rest of businesses within Life-Science Solutions segment of Thermo Fisher (TMO) are likely to have registered strong quarterly growth led by genetic sciences and bio production businesses.

OrganiGram (OGI) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

OrganiGram (OGI) is expected to have benefited from its focus on building brand equity and product launches in the fiscal third quarter despite pandemic-hit business conditions.

Turtle Beach, Eventbrite, Thermo Fisher Scientific, UBS Group and Canadian Pacific Railway highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Turtle Beach, Eventbrite, Thermo Fisher Scientific, UBS Group and Canadian Pacific Railway highlighted as Zacks Bull and Bear of the Day

Urmimala Biswas headshot

Medical Instruments Outlook Dull Amid Coronavirus Crisis

by Urmimala Biswas

Many sub domains within the medical instrument space are bearing the brunt of the coronavirus-led prolonged stay-at-home orders.

John Blank headshot

Time to Study Earnings: Global Week Ahead

by John Blank

"Bottoms-up" consensus expects earnings per share (EPS) to average $25.60 across Q2, down -6% from Q1, and close to a -40% drop in y/y terms. Guidance--if provided--becomes critical. So too will survival measures such as cash on hand.

Sheraz Mian headshot

Top Research Reports for Apple, Microsoft & TMobile

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Microsoft (MSFT) and TMobile US (TMUS).

Thermo Fisher Stock Rises on Solid Q2 Growth Expectation

by Zacks Equity Research

Thermo Fisher (TMO) provides encouraging Q2 guidance for organic growth.

Danaher Shares Gain 26% in 3 Months: What's Driving the Rally?

by Zacks Equity Research

Danaher (DHR), with 26% growth in shares in the past three months, benefits from healthy demand for its products and synergistic benefits from acquired assets despite the pandemic-led woes.

Pharmaceutical Wholesale to Aid Walgreens' (WBA) Q3 Earnings?

by Zacks Equity Research

Walgreen Boots' (WBA) international businesses in the third quarter is likely to have suffered a huge blow with international trade coming almost to a standstill.

Why Thermo Fisher (TMO) is Poised to Beat Earnings Estimates Again

by Zacks Equity Research

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Zacks Analyst Blog Highlights: Facebook, Thermo Fisher Scientific, McDonalds, NIKE and QUALCOMM

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Facebook, Thermo Fisher Scientific, McDonalds, NIKE and QUALCOMM

Manaswita Ghosh Dutta headshot

3 AI Healthcare Stocks to Ride Out the Coronavirus Resurgence

by Manaswita Ghosh Dutta

Efficient use of data by artificially intelligent applications has put into the spotlight their urgent need in the healthcare domain.

QIAGEN's (QGEN) Selloff Deal With Thermo Fisher Progresses

by Zacks Equity Research

QIAGEN's (QGEN) acquisition deal with Thermo Fisher receives approval from QIAGEN shareholders.